SCHEMBL6542672

SCHEMBL6542672

O=C(O)c1cc2cc(OCc3c(Cl)cccc3Cl)ccc2n1S(=O)(=O)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.59
BID P55957 1/20 0.59
MCL1 Q07820 1/20 0.59
CCR2 P41597 1/20 0.50
SRD5A2 P31213 1/20 0.45
NOD2 Q9HC29 2/20 0.42
NOD1 Q9Y239 2/20 0.42
ACLY P53396 1/20 0.41
GFER P55789 1/20 0.41
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
GALR3 O60755 1/20 0.40
GAA P10253 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC6 Q9UBN7 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7638737 0.92 BCL2 (0.59) BCL2BIDMCL1CCR2SRD5A2
SCHEMBL7644066 0.92 BCL2 (0.50) BCL2BIDMCL1CCR2SRD5A2
SCHEMBL6543181 0.90 MCL1 (0.59) BCL2BIDMCL1CCR2SRD5A2
SCHEMBL6542674 0.88 BCL2 (0.48) BCL2BIDMCL1CCR2SRD5A2
SCHEMBL7641620 0.84 MCL1 (0.52) BCL2BIDMCL1CCR2SRD5A2
SCHEMBL7638741 0.83 BCL2 (0.49) BCL2BIDMCL1CCR2SRD5A2
SCHEMBL7829429 0.80 CCR2 (0.66) BCL2BIDMCL1CCR2SRD5A2
SCHEMBL31159405 0.80 BCL2 (0.66) BCL2BIDMCL1CCR2SRD5A2
SCHEMBL7644069 0.80 BCL2 (0.40) BCL2BIDMCL1SRD5A2NOD2
SCHEMBL20761835 0.74 BCL2 (0.58) BCL2BIDMCL1SRD5A2PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469046-B1 FABH INHIBITORS WHICH ARE USEFUL AS ANTIBIOTICS FOR THE TREATMENT OF GRAM POSITIVE AND GRAM NEGATIVE BACTERIAL INFECTIONS SMITHKLINE BEECHAM CORPORATION 2002-10-22 US claimed
EP-1187607-A4 INDOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2004-01-28 EP disclosed
US-6469046-B1 FABH INHIBITORS WHICH ARE USEFUL AS ANTIBIOTICS FOR THE TREATMENT OF GRAM POSITIVE AND GRAM NEGATIVE BACTERIAL INFECTIONS SMITHKLINE BEECHAM CORPORATION 2002-10-22 US disclosed
EP-1187607-A1 INDOLE COMPOUNDS SmithKline Beecham Corporation (US) 2002-03-20 EP disclosed
WO-2000078309-A1 INDOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO disclosed